Medicine by Design is a strategic hub where scientists, engineers and clinicians converge to conceive and translate regenerative medicine approaches to transforming human health. Our community of researchers is from the University of Toronto and its affiliated hospitals, and we also work with the biotechnology industry, government and not-for-profit partners to integrate discovery and translation with biomanufacturing and clinical implementation.
What is Medicine by Design?
Medicine by Design is a bold initiative that was established in 2015, through an unprecedented investment of $114-million from the Canada First Research Excellence Fund (CFREF). Since its inception, Medicine by Design has sharpened the peaks of excellence and pushed the frontiers of regenerative medicine through large-scale investments in transformative, interdisciplinary research and translation projects and through the recruitment of world-class faculty and trainees.
By fostering convergence across leading centres in Toronto and supporting high-risk/high-reward research, Medicine by Design has built on the city’s legacy in regenerative medicine — from the discovery of stem cells to the cloning of T-cell receptor genes—to solidify the field as one of the most prolific areas of research across the Toronto Academic Health Sciences Network (TAHSN), which includes the University of Toronto and its affiliated hospitals.
Our key initiatives
- Strategic Research Stewardship— Curation of and funding for high-risk, transformational research that harnesses the world-class expertise of researchers and clinicians from a range of disciplines including the physical and life sciences, medicine, engineering and social sciences across the TAHSN.
- Translation and Commercialization Support – Offering early-stage translation support through the Pivotal Experiment Fund and Entrepreneur-in-Residence program, as well as strategic partnerships with regional incubators.
- Talent Development — Providing multidisciplinary regenerative medicine-focused training, mentorship and professional development programs through events and workshops and flagship trainee programs like Summer by Design and Building a Biotech Venture; and recruiting regenerative medicine faculty to the TAHSN.
- Clinical Implementation Support – Strategic training on topics like regenerative medicine in the clinic or planning early-stage clinical trials; and outreach to patients and communities we serve.
- Ecosystem Development – Building and promoting the global profile of the Toronto regenerative medicine community through international and national events, strategic partnerships, and public relations.
Our Strategic Vision
VISION: Toronto is a globally leading ecosystem for regenerative medicine innovation.
MISSION: To harness Toronto’s extraordinary expertise across convergent disciplines & institutions to invent, develop, scale & implement living therapies that will transform healthcare for Canada and the world.
Research Excellence – Transformative regenerative medicine innovation is rooted in world class research in engineering, medicine, and physical and social sciences.
Convergence – Interdisciplinary, multi-stakeholder, cross-sector collaborations are critical to tackling regenerative medicine’s most pressing challenges.
Equity – Overcoming the clinical, social and economic barriers that hinder the adoption of living therapies in all communities is fundamental to unlocking the promise of regenerative medicine.